Clinical Trial Update: Evaluation of the Diagnostic Potential of BAY1006578 in Probable Alzheimers Disease Patients Versus Healthy Volunteers and Radiation Dosimetry of BAY1006578 in Healthy Volunteers [Phase 1]

View source ↗

Summary

Phase 1 study evaluating BAY1006578 for diagnostic potential in probable Alzheimer's disease and assessing radiation dosimetry in healthy volunteers; the trial …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Alzheimer Disease

Drugs mentioned

• BAY1006578

Snippet

Sponsor: Life Molecular Imaging SA | Conditions: Diagnostic Imaging | Phase 1 | Status: COMPLETED